Inventor · disambiguated record
Gengfu Xiao
Also filed as: XIAO GENGFU
3 granted patents·14 pending applications·3 citations·filing 2020–2023
57Inventor score
Files withACAD OF MILITARY MEDICAL SCIENCES8SHANGHAI INST MATERIA MEDICA CAS7SHANGHAI INST OF MATERIA MEDICA CHINESSE ACADEMY OF SCIENCES1VIGONVITA LIFE SCIENCES CO LTD1
Top patents by PatentIndex Score
17 records- 0185US12351599B2Antiviral application of nucleoside analog or combination formulation containing nucleoside analogSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Granted Jul 8, 2025·1 cites·19 claims
- 0283US11919923B2Antiviral application of nucleoside analog or combination formulation containing nucleoside analogSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Granted Mar 5, 2024·1 cites·25 claims
- 0382US11318135B2Use of Favipiravir in treatment of coronavirus infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2021·Granted May 3, 2022·1 cites·16 claims
- 0459US2021346411A1Use of substituted aminopropionate compounds in treatment of sars-cov-2 infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2021·Application pending·0 cites
- 0556US2025282812A1Antiviral nucleoside analogue, and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0655US2021220353A1Use of favipiravir in treatment of coronavirus infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
- 0754US2021220377A1Use of substituted aminopropionate compounds in treatment of sars-cov-2 infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
- 0853US2024408065A1Cyano compound, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0953US2025296937A1Cyclic bisbenzyl tetrahydroisoquinoline compound, and preparation method therefor and use thereofSHANGHAI INST OF MATERIA MEDICA CHINESSE ACADEMY OF SCIENCES·Filed 2022·Application pending·0 cites
- 1049US2023312584A1Salt of nucleoside analog, and crystal form, pharmaceutical composition and use thereofVIGONVITA LIFE SCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1148US2024309012A1Isoquinoline compound, manufacturing method therefor, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1247US2023133600A1Pharmaceutical use of ketoamide-based compoundSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1344US2023071014A1Application of ritonavir in treating sars-cov-2 infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
- 1444US2023218606A1Use of 4-aminoquinoline compound in treatment of coronavirus infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
- 1543US2023210807A1Use of benzoate compound in treatment of sars-cov-2 infectionsACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
- 1643US2023138310A1Pharmaceutical use of aldehyde-based compoundSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Application pending·0 cites
- 1742US2023077704A1Application of nitazoxanide and active form thereof, tizoxanide, in treatment of sars-cov-2 infectionACAD OF MILITARY MEDICAL SCIENCES·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gengfu Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →